The new Express License service removes barriers to accessing this transformative gene editing technology for startups.An ...

An Express License provides fast, simple and affordable access to the CRISPR/Cas9 patent portfolio through ... including life sciences research tools, kits and reagents; discovery of novel targets ...

We recently compiled a list of the Top 11 CRISPR Stocks to Invest In. In this article, we are going to take a look at where ...

PCR products were then gel-purified using Zymoclean Gel DNA Recovery Kit (Zymo Research) and directly sequenced to evaluate off-target mutagenesis. Figure 1 Schematic diagram of CRISPR/Cas9 plant ...

The core components of CRISPR-based genome-editing therapies are bacterial proteins called nucleases that can stimulate ...

CRISPR Therapeutics AG (NASDAQ:CRSP), a leading biotechnology company specializing in gene-based medicines with a market capitalization of $3.45 billion, stands at a critical juncture as it navigates ...

Crispant analysis in zebrafish serves as a powerful tool for the rapid functional screening of genes implicated in bone fragility disorders, like osteogenesis imperfecta and osteoporosis.

Lehigh University bioenginering researcher Tomas Gonzalez-Fernandez recently secured funding through the National Science ...

In practice, automation makes it possible to edit, isolate, and screen thousands of clones for desired genetic changes made with CRISPR-Cas9 and transposase-based systems, ensuring that the best ...

In this article, we are going to take a look at where CRISPR Therapeutics AG (NASDAQ:CRSP) stands against other biotech stocks with the biggest upside potential. Improving Trends for Biotech ...